Stay updated on GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Recruitment status updated to No longer looking for participants, indicating enrollment has closed for this study. This update is logged under Revision: v3.6.0 on 2026-06-10.
    Difference
    1%
    Check dated 2026-06-14T07:46:37.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The history page displays a new site revision label, v3.5.5, replacing the previous v3.5.4, indicating an underlying platform update.
    Difference
    0.1%
    Check dated 2026-06-07T03:16:41.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.4) was added to the study history, replacing the previous v3.5.3 tag. This reflects an administrative update to the record history.
    Difference
    0.1%
    Check dated 2026-05-16T09:58:58.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov record history interface.
    Difference
    0.1%
    Check dated 2026-04-25T06:03:18.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history page.
    Difference
    0.1%
    Check dated 2026-04-18T03:50:21.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page history now includes a new revision labeled v3.5.0 and removes the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-20T04:55:31.000Z thumbnail image

Stay in the know with updates to GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2636771 Combo with Pembrolizumab in Melanoma Clinical Trial page.